Literature DB >> 27883

Preclinical toxicologic evaluation of nadolol, a new beta-adrenergic antagonist.

P L Sibley, G R Keim, J S Kulesza, B F Murphy, J L Myhre, H M Parish, Y H Yoon, I H Zaidi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 27883     DOI： 10.1016/0041-008x(78)90198-9

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  2 in total

1.  Protective effect of propranolol and nadolol on social defeat-induced behavioral impairments in rats.

Authors:  Safiyya Zaidi; Fatin Atrooz; Daniel Valdez; Hesong Liu; Camila Kochi; Richard A Bond; Samina Salim
Journal:  Neurosci Lett       Date:  2020-03-09       Impact factor: 3.046

Review 2.  Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.